SLC4A1 and neoplasm: DI/Pep1 is cleaved by MMP‐2 in the TME and transforms into aggregates with a high aspect ratio, thus controlling the drug release rate and prolonging the retention time of the drug in tumor tissues and enhancing site specificity and efficacy.